GEPIA analysis revealed that PGM5-AS1 was downregulated in most cancer types, especially in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC, Figure 1(a)). Here, PGM5 is linked to endocervical adenocarcinoma.